GLP-1RA-话题@MedSci

#GLP-1RA#

14篇内容 | 1572人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2249431, encodeId=949d2249431f7, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=2ad5104395dc' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a> <a href='/topic/show?id=f6818192258' target=_blank style='color:#2F92EE;'>#肥胖症#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Nature Medicine：除了降糖，胰高血糖素样肽-1受体激动剂(GLP-1RA)还能带来哪些意外惊喜？, objectType=article, longId=860780, objectId=ebc3860e805a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736833480786_8538692.jpg, objectUrl=/article/show_article.do?id=ebc3860e805a, replyNumber=0, likeNumber=19, createdTime=2025-01-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ebc3860e805a, moduleTitle=Nature Medicine：除了降糖，胰高血糖素样肽-1受体激动剂(GLP-1RA)还能带来哪些意外惊喜？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebc3860e805a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227206, encodeId=da1b222e206ac, content=<a href='/topic/show?id=88678152506' target=_blank style='color:#2F92EE;'>#肠促胰素#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=降糖和减重的背后，竟与8项诺奖密切相关！, objectType=article, longId=844340, objectId=afa28443408c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240914/1726306659945_8538692.png, objectUrl=/article/show_article.do?id=afa28443408c, replyNumber=0, likeNumber=69, createdTime=2024-09-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=afa28443408c, moduleTitle=降糖和减重的背后，竟与8项诺奖密切相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afa28443408c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224442, encodeId=1b63222444219, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=2ad5104395dc' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a> <a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a> <a href='/topic/show?id=5c331622ee1' target=_blank style='color:#2F92EE;'>#SGLT2i#</a>, objectTitle=一举两得，降糖又降心血管风险！JACC近150万人研究支持优先用这两类药, objectType=article, longId=842009, objectId=eb738420094d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240701/1719825954170_5579292.png, objectUrl=/article/show_article.do?id=eb738420094d, replyNumber=0, likeNumber=96, createdTime=2024-09-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=eb738420094d, moduleTitle=一举两得，降糖又降心血管风险！JACC近150万人研究支持优先用这两类药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb738420094d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2219163, encodeId=827122191638d, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=GLP-1RA真实世界研究成果在国际期刊发表，聚乙二醇洛塞那肽为糖尿病肾病患者带来多重受益，且可改善脂质水平, objectType=article, longId=837704, objectId=28aa83e70443, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240731/1722403770016_8538692.jpg, objectUrl=/article/show_article.do?id=28aa83e70443, replyNumber=0, likeNumber=69, createdTime=2024-08-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=28aa83e70443, moduleTitle=GLP-1RA真实世界研究成果在国际期刊发表，聚乙二醇洛塞那肽为糖尿病肾病患者带来多重受益，且可改善脂质水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28aa83e70443)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215625, encodeId=cb842215625ab, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a> <a href='/topic/show?id=023031264fd' target=_blank style='color:#2F92EE;'>#减肥#</a> <a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=不仅降糖减肥，还有防癌潜力！JAMA子刊：GLP-1药物或降低10种癌症风险, objectType=article, longId=835166, objectId=940b83516648, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240617/1718597656376_5579292.png, objectUrl=/article/show_article.do?id=940b83516648, replyNumber=0, likeNumber=114, createdTime=2024-07-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=940b83516648, moduleTitle=不仅降糖减肥，还有防癌潜力！JAMA子刊：GLP-1药物或降低10种癌症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=940b83516648)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214738, encodeId=101f2214e38dc, content=<a href='/topic/show?id=babc9413eb6' target=_blank style='color:#2F92EE;'>#运动#</a> <a href='/topic/show?id=9cac10191188' target=_blank style='color:#2F92EE;'>#骨骼健康#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=新型减肥药又有新发现！结合运动减重更有效，还能保持骨骼健康！, objectType=article, longId=834263, objectId=f3e4834263ef, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240712/1720795324622_1608702.png, objectUrl=/article/show_article.do?id=f3e4834263ef, replyNumber=0, likeNumber=96, createdTime=2024-07-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f3e4834263ef, moduleTitle=新型减肥药又有新发现！结合运动减重更有效，还能保持骨骼健康！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3e4834263ef)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212480, encodeId=c78522124800a, content=<a href='/topic/show?id=ead9898189d' target=_blank style='color:#2F92EE;'>#血糖#</a> <a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a> <a href='/topic/show?id=dac062129a' target=_blank style='color:#2F92EE;'>#DPP-4i#</a>, objectTitle=JDB杂志期刊精要 | 丹麦全国研究：GLP-1RA和DPP-4i的血糖控制水平与心血管结局比较, objectType=article, longId=832414, objectId=9ace83241434, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240629/1719620395300_5579292.png, objectUrl=/article/show_article.do?id=9ace83241434, replyNumber=0, likeNumber=99, createdTime=2024-06-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9ace83241434, moduleTitle=JDB杂志期刊精要 | 丹麦全国研究：GLP-1RA和DPP-4i的血糖控制水平与心血管结局比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ace83241434)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1622010, encodeId=fd111622010d0, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关, objectType=article, longId=729050, objectId=44efe290500e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44efe290500e, replyNumber=0, likeNumber=109, createdTime=2022-06-11, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44efe290500e, moduleTitle=JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44efe290500e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622009, encodeId=50e0162200983, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较, objectType=article, longId=295380, objectId=927829538021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927829538021, replyNumber=0, likeNumber=94, createdTime=2022-02-11, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927829538021, moduleTitle=JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927829538021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622008, encodeId=7cc8162200876, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, objectType=article, longId=219640, objectId=2997219640dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2997219640dc, replyNumber=0, likeNumber=87, createdTime=2021-11-03, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2997219640dc, moduleTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2997219640dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622007, encodeId=c41d162200e2b, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, objectType=article, longId=213502, objectId=ee6b2135028f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6b2135028f, replyNumber=0, likeNumber=90, createdTime=2021-07-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6b2135028f, moduleTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6b2135028f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622006, encodeId=83ff16220062f, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获, objectType=article, longId=191128, objectId=316219112851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=316219112851, replyNumber=0, likeNumber=108, createdTime=2020-04-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=316219112851, moduleTitle=Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=316219112851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622005, encodeId=2c5f1622005bf, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件, objectType=article, longId=179437, objectId=26881e943795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26881e943795, replyNumber=0, likeNumber=100, createdTime=2019-09-15, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26881e943795, moduleTitle=Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26881e943795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622004, encodeId=d9f81622004de, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响, objectType=article, longId=146095, objectId=6bd214609513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd214609513, replyNumber=0, likeNumber=106, createdTime=2018-08-09, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd214609513, moduleTitle=Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bd214609513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622003, encodeId=975f1622003aa, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半, objectType=article, longId=131184, objectId=80e513118486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e513118486, replyNumber=0, likeNumber=97, createdTime=2018-03-03, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e513118486, moduleTitle=Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e513118486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622002, encodeId=a7481622002af, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！, objectType=article, longId=131067, objectId=333a13106e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=333a13106e16, replyNumber=0, likeNumber=71, createdTime=2018-03-02, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=333a13106e16, moduleTitle=Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=333a13106e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622001, encodeId=05ef162200112, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？, objectType=article, longId=129344, objectId=1d9d12934457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d9d12934457, replyNumber=0, likeNumber=92, createdTime=2018-02-10, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d9d12934457, moduleTitle=J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d9d12934457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622000, encodeId=06b71622000f5, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, objectType=article, longId=95493, objectId=77e9954938e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e9954938e, replyNumber=0, likeNumber=84, createdTime=2017-04-13, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e9954938e, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e9954938e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621999, encodeId=1679162199912, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=0, createdTime=2016-09-25, rootId=0, userName=bioon10, userId=f14520287581, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621998, encodeId=d80b162199826, content=<a href='/topic/show?id=392480e970' target=_blank style='color:#2F92EE;'>#GLP-1RA#</a>, objectTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, objectType=article, longId=60432, objectId=0aae6043274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aae6043274, replyNumber=0, likeNumber=88, createdTime=2015-12-10, rootId=0, userName=bioon10, userId=f14520287581, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aae6043274, moduleTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aae6043274)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1RA

2020-05-29

梅斯管理员

#糖尿病# #肥胖症# #GLP-1RA#

Nature Medicine：除了降糖，胰高血糖素样肽-1受体激动剂(GLP-1RA)还能带来哪些意外惊喜？

2025-01-24发表于陕西省

梅斯管理员

#肠促胰素# #GLP-1RA#

降糖和减重的背后，竟与8项诺奖密切相关！

2024-09-23发表于上海

梅斯管理员

#糖尿病# #心血管风险# #GLP-1RA# #SGLT2i#

一举两得，降糖又降心血管风险！JACC近150万人研究支持优先用这两类药

2024-09-06发表于上海

梅斯管理员

#GLP-1RA#

GLP-1RA真实世界研究成果在国际期刊发表，聚乙二醇洛塞那肽为糖尿病肾病患者带来多重受益，且可改善脂质水平

2024-08-08发表于上海

梅斯管理员

#癌症# #减肥# #2型糖尿病# #GLP-1RA#

不仅降糖减肥，还有防癌潜力！JAMA子刊：GLP-1药物或降低10种癌症风险

2024-07-18发表于上海

梅斯管理员

#运动# #骨骼健康# #GLP-1RA#

新型减肥药又有新发现！结合运动减重更有效，还能保持骨骼健康！

2024-07-13发表于上海

梅斯管理员

#血糖# #GLP-1RA# #DPP-4i#

JDB杂志期刊精要 | 丹麦全国研究：GLP-1RA和DPP-4i的血糖控制水平与心血管结局比较

2024-06-30发表于上海

爆笑小医

#GLP-1RA#

JAMA Intern Med：GLP-1RA与胆囊或胆道事件相关

2022-06-11

爆笑小医

#GLP-1RA#

JAHA：SGLT2i和GLP-1RA对老年患者的心血管疗效比较

2022-02-11

爆笑小医

#GLP-1RA#

Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性

2021-11-03

爆笑小医

#GLP-1RA#

SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究

2021-07-01

爆笑小医

#GLP-1RA#

Lancet：从临床试验到临床实践，看真实世界中GLP-1RA的心血管获

2020-04-01

爆笑小医

#GLP-1RA#

Lancet Diabetes Endo：荟萃分析显示GLP-1RA可减少心血管事件

2019-09-15

爆笑小医

#GLP-1RA#

Hypertension：2型糖尿病患者长期应用短效GLP-1RA对系统血流动力学的影响

2018-08-09

爆笑小医

#GLP-1RA#

Am Heart J：胰岛素治疗的2型糖尿病患者添加GLP-1RA喜忧参半

2018-03-03

爆笑小医

#GLP-1RA#

Diabetes Obes Metab：T2DM患者联合服用Canagliflozin与GLP-1RA的疗效和安全性分析！

2018-03-02

爆笑小医

#GLP-1RA#

J Clin Lipidol：血脂异常的T2DM患者：GLP-1RAs+他汀是个不错的选择？

2018-02-10

爆笑小医

#GLP-1RA#

Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次

2017-04-13

bioon10

#GLP-1RA#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2016-09-25

bioon10

#GLP-1RA#

AIM：GLP-1RAs治疗2型糖尿病—受益和损害

2015-12-10